Lee Fixel

Fixel was born in 1980 and was raised near Fort Lauderdale, Florida. He is the eldest of three children and has two younger sisters.[2][3]

Fixel earned a Bachelor of Science in business administration, finance, and accounting at the Washington University in St. Louis.[2]

After graduation, Fixel became a licensed chartered financial analyst and began his career at Alkeon Capital Management, an investment firm.[2]

In 2006, Fixel joined Tiger Global Management, a New York-based investment firm.[4] He became a partner and head of the firm's private equity business, before his resignation in March 2019.[5] In a letter received by Reuters in March 2019, Fixel said he planned to continue investing independently.[6] He remains on the board of some portfolio companies,[7] such as Warby Parker.[8] He has also served on the board of Peloton.[5] Among his most notable portfolio investments are Stripe,[4] Peloton,[4] Freshworks,[9] and Spotify,[10] as well as late-stage investments, including Facebook.[2]

Fixel has invested in a number of Indian startups,[2] most famously e-commerce company Flipkart, where he is a member of the board of directors, since 2009.[7][11]

As of 2018, he has appeared on Forbes' Midas List six times over the course of his career.[2]

In 2020, Fixel launched the venture capital firm Addition and raised $1.3 billion to invest in early- and growth-stage startup companies.[12][13]

Fixel, along with his wife, Lauren Fixel, co-founded the Lauren and Lee Fixel Family Foundation.[2] Together, the Fixels are one of the largest contributors to The Michael J. Fox Foundation, a non-profit organization dedicated to Parkinson's disease research.[2]

In January 2019, the Lauren and Lee Fixel Family Foundation donated $20 million to the University of Florida and UF Health to establish the Norman Fixel Institute for Neurological Diseases.[14] The institute is focused on advancing research, technology, and clinical care for Parkinson's and other neurodegenerative diseases such as Alzheimer's disease and Amyotrophic lateral sclerosis (ALS).[15]